Relay Therapeutics is trading 6.9% down today at $18.64 amid a broader pullback in high-beta biotech names.
- The drop appears driven by sector-wide profit-taking rather than new company-specific news or data.
- The stock has rallied sharply in recent months on optimism around its oncology pipeline and capital raises.